Moreyra, E.

patient infarction ejection fraction survival 30 days hospital timi flow grade mortality hazard ratio group ejection fraction hazard ratio swets subs service study grade reperfusion trial hazard ratios center survival curves therapy death variable curve 2- year mortality benefit treatment 2 years function thrombolysi analysis hopital university artery streptokinase timi 3 flow effect mortality benefit tissue plasminogen activator advantage thrombolytic model service period survival advantage investigator minute george washington university circulation washington downloaded infarct 2- year period february simoon circ.ahajournals.org interval follow-up outcome werf f 90 minutes patency randomized lancet thrombolytic therapy study group .001 30- gusto-i timi 3 group trial study group timi flow grades simoons m 30- day mortality 688 days timi 2 confidence angiography